SEKISUI Diagnostics
Kevin Foley has a strong background in information technology management. Kevin is currently working as the Senior Director of Information Technology at SEKISUI Diagnostics. Prior to this, they held roles such as Director of Engineering at Validated Cloud, Director of Information Technology at Injured Workers Pharmacy, Director of Information Technology at Fractyl Laboratories Inc., and Senior Manager of IT Global Infrastructure Services at Thermo Fisher Scientific. Kevin also has experience at IPSEN, where they served as the Director of IT - Americas, IT Site Manager, and Senior System Administrator. Before that, they worked as a Desktop Support Associate at Wyeth and as a Help Desk Analyst at Getronics. Kevin has a proven track record of leading IT teams, implementing technology solutions, managing budgets and operations, and ensuring compliance with policies and regulations.
Kevin Foley has a diverse education history. In 2021, they attended Old Dominion University and earned a Master of Science (MS) degree in Cybersecurity, which they completed in 2022.
In 2009, Kevin enrolled in Villanova University and obtained a Master Certificate in IS/IT Project Management. Kevin completed this program in 2010, focusing on Information Technology Project Management.
From 2003 to 2005, Kevin studied at the University of Phoenix, where they earned an MBA with a specialization in Technology Management.
Kevin's undergraduate education took place at the University of Maine from 1989 to 1994. Kevin acquired a Bachelor of Science (BS) degree in Finance, General.
Additionally, Kevin holds the MCSE certification, but no information regarding the name of the institution or the specific month and year of obtaining this certification is provided.
This person is not in any teams
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals